HUM Humana Inc. - Fundamental Analysis
NEUTRAL
Sign in to save
Save this symbol to a watchlist or track a position.
HUM Stock | Fundamental Analysis & Investment Insights
NYSE
Healthcare
Healthcare Plans
Current Price
Live
$273.28
Analyst Target
$288.42
+5.5%
Upside
52W High
$315.35
52W Low
$206.87
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
72%
Analysis Accuracy
Humana's deterministic health score is weak, with a Piotroski F-Score of 4/9 indicating borderline financial stability. The company trades significantly above its Graham Number of $192.37 at a current price of $273.28, suggesting overvaluation on a defensive investing basis, though forward P/E of 22.37 reflects some growth optimism. Despite solid revenue growth of 11.10% and strong analyst target support at $288.42, earnings have sharply declined YoY by 59.30%, and profitability margins are thin, with ROE and ROA below sector averages. Technical trend is bearish and insider sentiment is neutral, balancing near-term risks against potential recovery.
Key Strengths
Revenue growth of 11.10% YoY outpaces sector average of 9.80%
Strong cash position implied by Current Ratio of 2.02 and Quick Ratio of 1.53
Debt/Equity of 0.70 is below sector average of 0.92, indicating conservative leverage
Analyst target price of $288.42 implies 5.5% upside from current levels
Consistent earnings beat streak: 3 out of last 4 quarters exceeded estimates
Key Risks
Piotroski F-Score of 4/9 signals weak financial health and low resilience to stress
Earnings collapsing: YoY EPS growth down 59.30%, Q/Q down 59.40%
Profit margin of 1.02% is far below sector average of 9.99%, raising sustainability concerns
Stock trades at 42% premium to Graham Number ($192.37 vs $273.28), increasing downside risk
Technical Trend score of 0/100 indicates strong bearish momentum
AI Fair Value Estimate
Based on comprehensive analysis
$210.5
-23.0% below current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare HUM against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning HUM from our newsroom.
Newest → oldest
No matching news yet.